MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.amjoto.2014.10.032

Медицинская библиотека · American journal of otolaryngology · 2014

Intratympanic dexamethasone versus high dosage of betahistine in the treatment of intractable unilateral Meniere disease.

Albu Silviu, Chirtes Felician, Trombitas Veronica, Nagy Alina, Marceanu Luigi, Babighian Gregorio, Trabalzini Franco

Сравнительное исследованиеСтатьяРандомизированное исследованиеПеревод пока не подготовлен

Аннотация

PURPOSE: The objective of our randomized, double-blind study was to compare the effectiveness of intratympanic (IT) dexamethasone versus high-dosage of betahistine in the treatment of patients with intractable unilateral Meniere disease (MD).

MATERIALS AND

METHODS

Sixty six patients with definite unilateral MD were randomly divided in two groups: Group A received a combination of IT dexamethasone (DX) and identical-appearing placebo pills while Group B received a combination of high-dosage betahistine and IT saline. Intratympanic injections were repeated for three times with an interlude of 3days. High-dosage of betahistine entailed 144mg/day. Mean outcome measures consisted of vertigo control, pure tone average (PTA), speech discrimination score, Functional Level Score, Dizziness Handicap Inventory and Tinnitus Handicap Inventory.

RESULTS

Fifty nine patients completed the study and were available at 12months for analysis. In Group A complete vertigo control (class A) was attained in 14 patients (46.6%) and substantial control (class B) in 7 patients (20%). In Group B, 12 patients (41%) achieved complete vertigo control (class A), 5 patients (17%) substantial control (class B). There is no statistical difference in vertigo control between the two treatment groups. In Group A hearing was unchanged in 14 patients and improved in 4 patients, while in Group B hearing was unchanged in 16 patients and improved in 2 patients.

CONCLUSIONS

Our preliminary results demonstrate that high-dosage of betahistine achieved similar outcomes as IT dexamethasone in the control of vertigo and hearing preservation.

Для цитирования: Albu Silviu, Chirtes Felician, Trombitas Veronica, Nagy Alina, Marceanu Luigi, Babighian Gregorio, Trabalzini Franco. Intratympanic dexamethasone versus high dosage of betahistine in the treatment of intractable unilateral Meniere disease.. American journal of otolaryngology. 2014. DOI: 10.1016/j.amjoto.2014.10.032.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.